Rare lephants
Screener

Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Nov 7, 2024 10-Q
144 Nov 7, 2024
8-K Nov 7, 2024 8-K
4 Sep 17, 2024 FORM 4
4 Sep 13, 2024 FORM 4
SC 13G/A Sep 10, 2024
8-K Sep 6, 2024 8-K
144 Sep 5, 2024
4 Sep 4, 2024 FORM 4
4 Sep 4, 2024 FORM 4
4 Sep 4, 2024 FORM 4
4 Sep 4, 2024 FORM 4
4 Sep 4, 2024 FORM 4
4 Sep 4, 2024 FORM 4
4 Sep 4, 2024 FORM 4
144 Aug 21, 2024
144 Aug 13, 2024
144 Aug 12, 2024
S-8 Aug 9, 2024 S-8
4 Aug 9, 2024 4
3 Aug 9, 2024 3
8-K Aug 9, 2024 8-K
10-Q Aug 8, 2024 10-Q
8-K Aug 8, 2024 8-K
4 Jun 10, 2024 FORM 4
← Newer Page 8 of 54 · 1328 filings Older →